/Investor DB

WARF

Foundation

Madison · Pre-Seed–Seed · 6 people tracked

Find your way into WARF

Sign up to see every warm intro you have to WARF

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the WARF team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

WARF serves as the patenting and licensing arm of the University of Wisconsin-Madison, formed by university visionaries to translate academic research into solutions for global problems. For roughly a century it has helped advance transformative university discoveries into the marketplace, managing a cycle that spans research, discovery, commercialization and investment. Its focus is on supporting and commercializing innovations emerging from UW-Madison research rather than acting as a conventional sector-focused venture fund.

Invests inBiotechDeep TechSector AgnosticMadisonUnited States

Source: firm website, verified Oct 17, 2026.

Stage
Pre-Seed–Seed
HQ
Madison, Wisconsin, US
Instruments
Grants · Equity
Founded
1925
Tracked investments
1

Team · 6 people

from the firm's website & public directories
Greg Keenan· Senior Directorin

Greg Keenan is Senior Director and Partner at WARF Ventures and the WARF Accelerator at the Wisconsin Alumni Research Foundation, where he leads early-stage investments from a $150M venture fund and directs the accelerator's translational gap funding for UW-Madison faculty and student innovators. He has led 20 startup investments that have collectively raised over $650M in venture capital. Earlier in his career, he led business development and engineering teams at Virent, LiquiGlide, and Air Products.

Goutham Narla· Chief Scientific Officer, WARF Therapeuticsin

Physician-scientist and drug discovery leader appointed to lead the next phase of WARF Therapeutics' translational medicine program.

Jeanan Yasiri Moe· Director of Strategic Communications and Public Affairs
Joshua Carson· Venture Managerin
Michael J. Partsch· Chief Venture Officer
Steven Andrzejewski· Senior Venture Analyst

What they invest in

from 1 of 1 portfolio companies

Deep Tech ×1Quantum Computing ×1Semiconductors ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Qolabqolab.aiin✓ verified

Qolab applies advanced semiconductor fabrication and integration to build superconducting quantum hardware, addressing scaling bottlenecks such as qubit yield and component integration.

Deep TechQuantum ComputingSemiconductorsMadison, US

Alan Ho(Executive Officer, Director, Promoter)inJohn Martinis(CTO)inRobert McDermott(Director)

BoardMichael Kim(Director)

Co-investorsOctave Ventures LlcPhoenix Venture PartnersApplied VenturesDevelopment Bank of Japan

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does WARF invest at?
WARF invests at the Pre-Seed, Seed stages.
What sectors does WARF focus on?
WARF focuses on Biotech, Deep Tech, Sector Agnostic.
Where is WARF located?
WARF is headquartered in Madison, US.

Media · Podcasts & interviews

from their channel

Happy Holidays from WARF!

Wisconsin Alumni Research Foundation (WARF)

Targeted eye therapy could improve treatment for vision loss

Wisconsin Alumni Research Foundation (WARF)

Ecofriendly herbicide offers targeted weed control

Wisconsin Alumni Research Foundation (WARF)

Recyclable protein degraders could boost cancer immunotherapy

Wisconsin Alumni Research Foundation (WARF)

New light-extracting structure could boost quantum device performance

Wisconsin Alumni Research Foundation (WARF)

Smart scheduling over composable GPUs

Wisconsin Alumni Research Foundation (WARF)

Images

WARF photoWARF photoWARF photoWARF photoWARF photo

Similar investors

Featured in lists